These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5855172)

  • 21. [Concepts and methods of treatment of pulmonary and extra-pulmonary tuberculosis].
    Fortic B
    Plucne Bolesti; 1984; 36(1-2):103-14. PubMed ID: 6334860
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study on the therapy of pulmonary tuberculosis with Capreomycin].
    Saishin Igaku; 1966 Jan; 21(1):164-77. PubMed ID: 5965936
    [No Abstract]   [Full Text] [Related]  

  • 23. [Symposium on comparison of clinical efficacy among various kinds of chemotherapeutic regimens for pulmonary tuberculosis. 1. Results of studies by the Tuberculosis Research Committee].
    Gomi J
    Kekkaku; 1966 Sep; 41(9):431-6. PubMed ID: 5975804
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs].
    Hornung S; Polończyk M
    Gruzlica; 1965 Oct; 33(10):886-9. PubMed ID: 5881604
    [No Abstract]   [Full Text] [Related]  

  • 25. [Recovery of patients from pulmonary tuberculosis].
    Katslan IaD
    Vrach Delo; 1965 Oct; 10():147-8. PubMed ID: 5873552
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience with ambulatory treatment of patients with pulmonary tuberculosis].
    Mikulinskiĭ IM
    Probl Tuberk; 1966; 44(12):5-7. PubMed ID: 6003080
    [No Abstract]   [Full Text] [Related]  

  • 27. [Specific serum antimycobacterial activity test in pulmonary tuberculosis patients].
    Yamagata Y; Konomata T
    Iryo; 1966 May; 20(5):450-5. PubMed ID: 5963052
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the behavior of some enzymatic activities of neoplastic tissues (glutamic-oxalacetic transaminases, glutamic-pyruvic transaminases, aldolase, lactic hydrogenase and malic dehydrogenase). I. Breast neoplasms].
    PETRONIO L; AULISA B; PALAMARA F; GIRALDI A
    Arch De Vecchi Anat Patol; 1960 Nov; 34():1-20. PubMed ID: 13734928
    [No Abstract]   [Full Text] [Related]  

  • 29. [Follow-up studies on patients with chronic pulmonary tuberculosis treated with secondary tuberculostatic agents].
    Böszörményi M; Faust I; Barát I; Schweiger O
    Probl Tuberk; 1965; 43(8):39-45. PubMed ID: 5869918
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemotherapy in patients with chronic pulmonary tuberculosis].
    Bernard E
    Tuberkuloza; 1966; 18(1-3):11-5. PubMed ID: 16296060
    [No Abstract]   [Full Text] [Related]  

  • 31. [Advances in the treatment of pulmonary tuberculosis in children].
    Alcaide Megias J; Altet Gómez MN
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():12-7. PubMed ID: 6419658
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of antibacterial treatment of patients with bacteriologically confirmed pulmonary tuberculosis in Poland 1982].
    Szczuka I
    Pneumonol Pol; 1984 Sep; 52(9):409-18. PubMed ID: 6442409
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antibacterial treatment and ways to increase its efficiency in patients with pulmonary tuberculosis].
    Pilipchuk NS; Pavlenko NO; Sin'kovskiĭ PV; Lagodzinskaia NIa; Kharchenko EF; Kolesnikova ZhIa
    Vrach Delo; 1966 Oct; 10():59-64. PubMed ID: 5996365
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effectivity of treatment of patients with non-destructive pulmonary tuberculosis].
    Kal'neva AM; Erlikh BL; Livshits SI
    Probl Tuberk; 1966; 44(5):37-40. PubMed ID: 5993148
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems in the treatment of patients with pulmonary tuberculosis].
    Chukanov VI
    Probl Tuberk; 1997; (4):17-9. PubMed ID: 9333807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical limits of microbial resistance to secondary antitubercular agents].
    Sakurai H; Hashimoto T
    Saishin Igaku; 1966 Jan; 21(1):88-94. PubMed ID: 5965948
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of sulphur water from the Mateczny II spring on the activity of the adrenal aldolase and aminotransferases].
    Tarnawski A; Wajdowicz A
    Przegl Lek; 1970 Sep; 26(9):731-3. PubMed ID: 5472568
    [No Abstract]   [Full Text] [Related]  

  • 39. [DIAGNOSTIC SIGNIFICANCE OF DETERMINING BLOOD ALDOLASE ACTIVITY IN THE THERAPEUTIC CLINIC].
    ANSHELEVICH IuV
    Sov Med; 1963 Jun; 27():49-55. PubMed ID: 14069288
    [No Abstract]   [Full Text] [Related]  

  • 40. [Leukergy in patients with pulmonary tuberculosis treated for the first time with antitubercular drugs].
    Przemyska B
    Gruzlica; 1967; 35(11):1169-74. PubMed ID: 6063620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.